Diverse pathways of oxidative folding of disulfide proteins: underlying causes and folding models.

The pathway of oxidative folding of disulfide proteins exhibits a high degree of diversity, which is manifested mainly by distinct structural heterogeneity and diverse rearrangement pathways of folding intermediates. During the past two decades, the scope of this diversity has widened through studies of more than 30 disulfide-rich proteins by various laboratories. A more comprehensive landscape of the mechanism of protein oxidative folding has emerged. This review will cover three themes. (1) Elaboration of the scope of diversity of disulfide folding pathways, including the two opposite extreme models, represented by bovine pancreatic trypsin inhibitor (BPTI) and hirudin. (2) Demonstration of experimental evidence accounting for the underlying mechanism of the folding diversity. (3) Discussion of the convergence between the extreme models of oxidative folding and models of conventional conformational folding (framework model, hydrophobic collapse model).

[1]  D. Craik,et al.  Knots in Rings , 2006, Journal of Biological Chemistry.

[2]  J. Calvete,et al.  Characterizing the Tick Carboxypeptidase Inhibitor , 2006, Journal of Biological Chemistry.

[3]  F. Avilés,et al.  Major kinetic traps for the oxidative folding of leech carboxypeptidase inhibitor. , 2003, Biochemistry.

[4]  G. Wider,et al.  NMR determination of residual structure in a urea-denatured protein, the 434-repressor. , 1992, Science.

[5]  P. S. Kim,et al.  Disulfide determinants of calcium-induced packing in alpha-lactalbumin. , 1996, Biochemistry.

[6]  B. Chatrenet,et al.  The disulfide folding pathway of hirudin elucidated by stop/go folding experiments. , 1993, The Journal of biological chemistry.

[7]  F. Avilés,et al.  Oxidative folding of leech-derived tryptase inhibitor via native disulfide-bonded intermediates. , 2008, Antioxidants & redox signaling.

[8]  K. Dill.  Dominant forces in protein folding. , 1990, Biochemistry.

[9]  K. Dill,et al.  The protein folding problem. , 1993, Annual review of biophysics.

[10]  W. Kauzmann.  Some factors in the interpretation of protein denaturation. , 1959, Advances in protein chemistry.

[11]  Sheena E Radford,et al.  An expanding arsenal of experimental methods yields an explosion of insights into protein folding mechanisms , 2009, Nature Structural &Molecular Biology.

[12]  H. Scheraga,et al.  Structural determinants of oxidative folding in proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Dill,et al.  From Levinthal to pathways to funnels , 1997, Nature Structural Biology.

[14]  L. Berliner,et al.  alpha-Lactalbumin: structure and function. , 2000, FEBS letters.

[15]  Jui-Yoa Chang,et al.  The structure of denatured bovine pancreatic trypsin inhibitor (BPTI) , 2000, FEBS letters.

[16]  Jiang Wu,et al.  Trapping of intermediates during the refolding of recombinant human epidermal growth factor (hEGF) by cyanylation, and subsequent structural elucidation by mass spectrometry , 1998, Protein Science.

[17]  H. Scheraga,et al.  Oxidative folding of proteins. , 2000, Accounts of chemical research.

[18]  F. Avilés,et al.  The NMR Structures of the Major Intermediates of the Two-domain Tick Carboxypeptidase Inhibitor Reveal Symmetry in Its Folding and Unfolding Pathways* , 2008, Journal of Biological Chemistry.

[19]  F. Avilés,et al.  Scrambled Isomers as Key Intermediates in the Oxidative Folding of Ligand Binding Module 5 of the Low Density Lipoprotein Receptor* , 2008, Journal of Biological Chemistry.

[20]  M. Tuite,et al.  Protein disulphide isomerase: building bridges in protein folding. , 1994, Trends in biochemical sciences.

[21]  M. Weiss,et al.  In Vitro Refolding of Human Proinsulin , 2003, The Journal of Biological Chemistry.

[22]  Masa Cemazar,et al.  Protein disulfide isomerase: the structure of oxidative folding. , 2006, Trends in biochemical sciences.

[23]  H. Gilbert.  Protein Disulfide Isomerase and Assisted Protein Folding* , 1997, The Journal of Biological Chemistry.

[24]  P. S. Kim,et al.  Formation of a native‐like subdomain in a partially folded intermediate of bovine pancreatic trypsin inhibitor , 1994, Protein science : a publication of the Protein Society.

[25]  P. Horowitz,et al.  Residual structure in urea-denatured chaperonin GroEL. , 1995, Biochemistry.

[26]  T. Creighton,et al.  Structural characterization of the disulfide folding intermediates of bovine alpha-lactalbumin. , 1993, Biochemistry.

[27]  M. Uhlén,et al.  Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein. , 1994, Biochemistry.

[28]  F. Avilés,et al.  Role of Kinetic Intermediates in the Folding of Leech Carboxypeptidase Inhibitor* , 2004, Journal of Biological Chemistry.

[29]  Jui-Yoa Chang.  A Two-Stage Mechanism for the Reductive Unfolding of Disulfide-containing Proteins* , 1997, The Journal of Biological Chemistry.

[30]  R. Broglia,et al.  Early events in protein folding: Is there something more than hydrophobic burst? , 2008, Protein science : a publication of the Protein Society.

[31]  S. Pongor,et al.  Oxidative folding of Amaranthus alpha-amylase inhibitor: disulfide bond formation and conformational folding. , 2004, The Journal of biological chemistry.

[32]  F. Markwardt,et al.  [The reaction between hirudin and thrombin]. , 1958, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[33]  A. Fersht.  Optimization of rates of protein folding: the nucleation-condensation mechanism and its implications. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Creighton,et al.  Two-dimensional 1H nuclear magnetic resonance study of the (5-55) single-disulphide folding intermediate of bovine pancreatic trypsin inhibitor. , 1991, Journal of molecular biology.

[35]  NMR structure determination of tick anticoagulant peptide (TAP) , 1995, Protein science : a publication of the Protein Society.

[36]  C. Tanford.  Contribution of Hydrophobic Interactions to the Stability of the Globular Conformation of Proteins , 1962 .

[37]  D. Goldenberg,et al.  Native and non-native intermediates in the BPTI folding pathway. , 1992, Trends in biochemical sciences.

[38]  B. Chatrenet,et al.  The folding of hirudin adopts a mechanism of trial and error. , 1992, The Journal of biological chemistry.

[39]  F. Avilés,et al.  Folding of small disulfide-rich proteins: clarifying the puzzle. , 2006, Trends in biochemical sciences.

[40]  Role of the 6‐20 disulfide bridge in the structure and activity of epidermal growth factor , 1998, Protein science : a publication of the Protein Society.

[41]  D. Goldenberg,et al.  Probing the determinants of disulfide stability in native pancreatic trypsin inhibitor. , 1993, Biochemistry.

[42]  Jonathan S. Weissman,et al.  A kinetic explanation for the rearrangement pathway of BPTI folding , 1995, Nature Structural Biology.

[43]  T. Creighton,et al.  Experimental studies of protein folding and unfolding. , 1978, Progress in biophysics and molecular biology.

[44]  T. Creighton,et al.  Intermediates in the refolding of reduced ribonuclease A. , 1979, Journal of molecular biology.

[45]  S. Hober,et al.  Disulfide exchange folding of insulin-like growth factor I. , 1992, Biochemistry.

[46]  F. Avilés,et al.  Insights into the two-domain architecture of the metallocarboxypeptidase inhibitor from the Ascaris parasite inferred from the mechanism of its oxidative folding. , 2009, Biochemistry.

[47]  J. Udgaonkar,et al.  Initial hydrophobic collapse in the folding of barstar , 1995, Nature.

[48]  D. Craik,et al.  Oxidative folding of the cystine knot motif in cyclotide proteins. , 2005, Protein and peptide letters.

[49]  J. Watson,et al.  Probing the Folding Pathways of Long R3Insulin-like Growth Factor-I (LR3IGF-I) and IGF-I via Capture and Identification of Disulfide Intermediates by Cyanylation Methodology and Mass Spectrometry* , 1999, The Journal of Biological Chemistry.

[50]  D. Shortle,et al.  Persistence of Native-Like Topology in a Denatured Protein in 8 M Urea , 2001, Science.

[51]  N. C. Price,et al.  How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.

[52]  Jui-Yoa Chang.  Evidence for the underlying cause of diversity of the disulfide folding pathway. , 2004, Biochemistry.

[53]  K. Plaxco,et al.  Is There or Isn't There? The Case for (and Against) Residual Structure in Chemically Denatured Proteins , 2005, Critical reviews in biochemistry and molecular biology.

[54]  P. S. Kim,et al.  Role of a subdomain in the folding of bovine pancreatic trypsin inhibitor , 1990, Nature.

[55]  P. S. Kim,et al.  The pro region of BPTI facilitates folding , 1992, Cell.

[56]  L. Chiche,et al.  Characterization and 2D NMR study of the stable [9–21, 15–27] 2 disulfide intermediate in the folding of the 3 disulfide trypsin inhibitor EETI II , 1993, Protein science : a publication of the Protein Society.

[57]  H. Senn,et al.  The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution. , 1997, Journal of molecular biology.

[58]  O. Ptitsyn.  Protein folding: Hypotheses and experiments , 1987 .

[59]  D. Rolison,et al.  Electrocatalysis and charge-transfer reactions at redox-modified zeolites. , 2000, Accounts of chemical research.

[60]  P. S. Kim,et al.  Intermediates in the folding reactions of small proteins. , 1990, Annual review of biochemistry.

[61]  L. Berliner,et al.  α‐Lactalbumin: structure and function , 2000 .

[62]  L Mayne,et al.  Protein folding studied using hydrogen-exchange labeling and two-dimensional NMR. , 1992, Annual review of biophysics and biomolecular structure.

[63]  D. Shortle,et al.  NMR analysis of the residual structure in the denatured state of an unusual mutant of staphylococcal nuclease. , 1993, Structure.

[64]  D. Baker,et al.  NMR characterization of residual structure in the denatured state of protein L. , 2000, Journal of molecular biology.

[65]  Jui-Yoa Chang,et al.  Pathway of oxidative folding of alpha-lactalbumin: a model for illustrating the diversity of disulfide folding pathways. , 2002, Biochemistry.

[66]  H. Scheraga,et al.  Disulfide bonds and protein folding. , 2000, Biochemistry.

[67]  Jui-Yoa Chang,et al.  Production of disulfide‐linked hirudin dimer by in vitro folding , 1993, FEBS letters.

[68]  C. Anfinsen.  Principles that govern the folding of protein chains. , 1973, Science.

[69]  F. Avilés,et al.  The Unfolding Pathway and Conformational Stability of Potato Carboxypeptidase Inhibitor* , 2000, The Journal of Biological Chemistry.

[70]  S. Radford,et al.  Protein folding: progress made and promises ahead. , 2000, Trends in biochemical sciences.

[71]  K. Ohlsson,et al.  Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Jui-Yoa Chang.  The functional domain of hirudin, a thrombin‐specific inhibitor , 1983, FEBS letters.

[73]  Robert Huber,et al.  The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode. , 2005, Journal of molecular biology.

[74]  H. Scheraga,et al.  Kinetic studies of the regeneration of recombinant hirudin variant 1 with oxidized and reduced dithiothreitol. , 1997, Biochemistry.

[75]  L. Li,et al.  A Major Kinetic Trap for the Oxidative Folding of Human Epidermal Growth Factor* , 2001, The Journal of Biological Chemistry.

[76]  H. Dyson,et al.  Unfolded proteins and protein folding studied by NMR. , 2004, Chemical reviews.

[77]  A. Ménez,et al.  Slow folding of three-fingered toxins is associated with the accumulation of native disulfide-bonded intermediates. , 2001, Biochemistry.

[78]  Jui-Yoa Chang,et al.  Divergent folding pathways of two homologous proteins, BPTI and tick anticoagulant peptide: compartmentalization of folding intermediates and identification of kinetic traps. , 2005, Archives of biochemistry and biophysics.

[79]  T. Creighton,et al.  (14-38, 30-51) double-disulphide intermediate in folding of bovine pancreatic trypsin inhibitor: a two-dimensional 1H nuclear magnetic resonance study. , 1991, Journal of molecular biology.

[80]  D. Goldenberg,et al.  Effects of amino acid replacements on the reductive unfolding kinetics of pancreatic trypsin inhibitor. , 1994, Biochemistry.

[81]  P. S. Kim,et al.  A third native one-disulphide intermediate in the folding of bovine pancreatic trypsin inhibitor , 1995, Nature Structural Biology.

[82]  A. Bulychev,et al.  The Underlying Mechanism for the Diversity of Disulfide Folding Pathways* , 2000, The Journal of Biological Chemistry.

[83]  D. E. Smith,et al.  Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. , 1990, Science.

[84]  H. Scheraga,et al.  Regeneration of bovine pancreatic ribonuclease A: detailed kinetic analysis of two independent folding pathways. , 1998, Biochemistry.

[85]  R. Huber,et al.  The Three-dimensional Structure of Recombinant Leech-derived Tryptase Inhibitor in Complex with Trypsin , 1997, The Journal of Biological Chemistry.

[86]  R. L. Baldwin,et al.  The search for folding intermediates and the mechanism of protein folding. , 2008, Annual review of biophysics.

[87]  R. L. Baldwin,et al.  How does protein folding get started? , 1989, Trends in biochemical sciences.

[88]  H A Scheraga,et al.  Coupling of conformational folding and disulfide-bond reactions in oxidative folding of proteins. , 2001, Biochemistry.

[89]  Jonathan A. Jones,et al.  Oxidative folding intermediates with nonnative disulfide bridges between adjacent cysteine residues , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[90]  R. Huber,et al.  Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite , 2009, Proceedings of the National Academy of Sciences.

[91]  W. Bode,et al.  Crystal structure of the thrombin‐hirudin complex: a novel mode of serine protease inhibition. , 1990, The EMBO journal.

[92]  Robert F Gahl,et al.  Dissimilarity in the oxidative folding of onconase and ribonuclease A, two structural homologues. , 2008, Protein engineering, design & selection : PEDS.

[93]  R. Huber,et al.  The 2.5 A X‐ray crystal structure of the acid‐stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha‐chymotrypsin. , 1988, The EMBO journal.

[94]  T. Creighton,et al.  Further experimental studies of the disulfide folding transition of ribonuclease A , 1988, Proteins.

[95]  V. Uversky,et al.  The chicken–egg scenario of protein folding revisited , 2002, FEBS letters.

[96]  P. Schindler,et al.  The Disulfide Structures of Scrambled Hirudins (*) , 1995, The Journal of Biological Chemistry.

[97]  T. Creighton,et al.  The disulfide folding pathway of BPTI. , 1992, Science.

[98]  E. Querol,et al.  The disulfide folding pathway of potato carboxypeptidase inhibitor. , 1994, The Journal of biological chemistry.

[99]  Alan R. Fersht,et al.  From the first protein structures to our current knowledge of protein folding: delights and scepticisms , 2008, Nature Reviews Molecular Cell Biology.

[100]  T. Creighton.  Disulfide bonds as probes of protein folding pathways. , 1986, Methods in enzymology.

[101]  F. Avilés,et al.  Deciphering the Structural Basis That Guides the Oxidative Folding of Leech-derived Tryptase Inhibitor* , 2009, The Journal of Biological Chemistry.

[102]  A. Mark,et al.  The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein. , 2008, Structure.

[103]  C. Yu,et al.  Fully oxidized scrambled isomers are essential and predominant folding intermediates of cardiotoxin‐III , 2006, FEBS letters.

[104]  J. Chang.  Stability of hirudin, a thrombin-specific inhibitor. The structure of alkaline-inactivated hirudin. , 1991, The Journal of biological chemistry.

[105]  J. Onuchic,et al.  Toward an outline of the topography of a realistic protein-folding funnel. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[106]  P. S. Kim,et al.  Complete folding of bovine pancreatic trypsin inhibitor with only a single disulfide bond. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[107]  G. Bulaj,et al.  Oxidative folding of conotoxins sharing an identical disulfide bridging framework , 2005, The FEBS journal.

[108]  A. Matagne,et al.  The folding process of hen lysozyme: a perspective from the ‘new view’ , 1998, Cellular and Molecular Life Sciences CMLS.

[109]  R. Huber,et al.  The structure of a complex of recombinant hirudin and human alpha-thrombin. , 1990, Science.

[110]  P G Wolynes,et al.  Protein folding mechanisms and the multidimensional folding funnel , 1998, Proteins.

[111]  A. Fersht,et al.  Is there a unifying mechanism for protein folding? , 2003, Trends in biochemical sciences.

[112]  T. Creighton,et al.  Pathway of disulfide-coupled unfolding and refolding of bovine alpha-lactalbumin. , 1993, Biochemistry.

[113]  Jui-Yoa Chang.  Denatured States of Tick Anticoagulant Peptide , 1999, The Journal of Biological Chemistry.

[114]  J. Miller,et al.  Oxidative refolding of insulin-like growth factor 1 yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway. , 1993, Biochemistry.

[115]  E. Querol,et al.  Mutations in the N- and C-terminal Tails of Potato Carboxypeptidase Inhibitor Influence Its Oxidative Refolding Process at the Reshuffling Stage* , 2001, The Journal of Biological Chemistry.

[116]  C. Yu,et al.  Unfolding and refolding of cardiotoxin III elucidated by reversible conversion of the native and scrambled species. , 1998, Biochemistry.

[117]  Harold A. Scheraga,et al.  Mechanism of reductive protein unfolding , 1995, Nature Structural Biology.

[118]  P S Kim,et al.  Kinetic role of nonnative species in the folding of bovine pancreatic trypsin inhibitor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[119]  Jui-Yoa Chang,et al.  Conformational stability of secretory leucocyte protease inhibitor: a protein with no hydrophobic core and very little secondary structure. , 2006, Biochimica et biophysica acta.

[120]  Robert F Gahl,et al.  Oxidative folding pathway of onconase, a ribonuclease homologue: insight into oxidative folding mechanisms from a study of two homologues. , 2009, Biochemistry.

[121]  Folding of omega-conotoxins. 1. Efficient disulfide-coupled folding of mature sequences in vitro. , 1996, Biochemistry.

[122]  B. Bowler,et al.  Denatured state thermodynamics: residual structure, chain stiffness and scaling factors. , 2001, Journal of molecular biology.

[123]  C. Schultz.  Illuminating folding intermediates , 2000, Nature Structural Biology.

[124]  Jui-Yoa Chang,et al.  Pathway of oxidative folding of secretory leucocyte protease inhibitor: an 8-disulfide protein exhibits a unique mechanism of folding. , 2006, Biochemistry.

[125]  J. Miller,et al.  Putative folding pathway of insulin-like growth factor-I. , 1997, Archives of biochemistry and biophysics.

[126]  J. Carver,et al.  Probing the disulfide folding pathway of insulin-like growth factor-I. , 1999, Biotechnology and bioengineering.

[127]  C. Royer.  Probing Protein Folding and Conformational Transitions with Fluorescence , 2006 .

[128]  Jui-Yoa Chang,et al.  Structure and Heterogeneity of the One- and Two-Disulfide Folding Intermediates of Tick Anticoagulant Peptide , 2000, Journal of protein chemistry.

[129]  D. Craik,et al.  Disulfide Folding Pathways of Cystine Knot Proteins , 2003, The Journal of Biological Chemistry.

[130]  M. Narayan,et al.  The oxidoreductase behavior of protein disulfide isomerase impedes fold maturation of endoplasmic reticulum-processed proteins in the pivotal structure-coupled step of oxidative folding: implications for subcellular protein trafficking. , 2010, Biochemistry.

[131]  T. Creighton,et al.  The partially folded conformation of the Cys-30 Cys-51 intermediate in the disulfide folding pathway of bovine pancreatic trypsin inhibitor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[132]  H. Scheraga,et al.  Regeneration of bovine pancreatic ribonuclease A: identification of two nativelike three-disulfide intermediates involved in separate pathways. , 1998, Biochemistry.

[133]  G. Bulaj,et al.  Efficient oxidative folding of conotoxins and the radiation of venomous cone snails , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[134]  S Banu Ozkan,et al.  The protein folding problem: when will it be solved? , 2007, Current opinion in structural biology.

[135]  B. Olivera,et al.  Conus venoms: a rich source of novel ion channel-targeted peptides. , 2004, Physiological reviews.

[136]  P. S. Kim,et al.  Reexamination of the folding of BPTI: predominance of native intermediates , 1991, Science.

[137]  P. Schindler,et al.  The Disulfide Folding Pathway of Human Epidermal Growth Factor (*) , 1995, The Journal of Biological Chemistry.

[138]  M. Sardana,et al.  Determination of disulfide bond pairs and stability in recombinant tick anticoagulant peptide. , 1991, The Journal of biological chemistry.

[139]  D. Goldenberg,et al.  Amino acid replacement that eliminates kinetic traps in the folding pathway of pancreatic trypsin inhibitor. , 1993, Biochemistry.

[140]  Jui-Yoa Chang,et al.  The Structure of Denatured α-Lactalbumin Elucidated by the Technique of Disulfide Scrambling , 2001, The Journal of Biological Chemistry.

[141]  Oxidative folding of ω‐conotoxin MVIIC: Effects of temperature and salt , 1996 .

[142]  J. Chang.  The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI. , 1996, Biochemistry.

[143]  S. Millard,et al.  Dscam-mediated cell recognition regulates neural circuit formation. , 2008, Annual Review of Cell and Developmental Biology.